Sera Prognostics, Inc. (SERA)
2.16
-0.14
(-6.09%)
USD |
NASDAQ |
Apr 07, 16:00
2.195
+0.04
(+1.62%)
After-Hours: 20:00
Sera Prognostics Profit Margin (Quarterly) : -78.81K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | -43.20K% |
| Celldex Therapeutics, Inc. | -67.20K% |
| Plus Therapeutics, Inc. | -417.9% |
| Atossa Therapeutics, Inc. | -- |
| Abeona Therapeutics, Inc. | -377.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.10% |
| Return on Assets | -31.09% |
| Return on Invested Capital | -40.42% |
| Gross Profit Margin (Quarterly) | -2.47K% |
| Operating Margin (Quarterly) | -89.54K% |
| Return on Net Operating Assets | -931.9% |